Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Angiotensin-II and vascular endothelial growth factor interaction plays an important role in rat liver fibrosis development.

Angiotensin-II and vascular endothelial growth factor interaction plays an important role in rat liver fibrosis development. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Angiotensin-II and vascular endothelial growth factor interaction plays an important role in rat liver fibrosis development. Abstract Text:

    hitoshi yoshijiHitoshi Yoshiji,shigeki kuriyamaShigeki Kuriyama,ryuichi noguchiRyuichi Noguchi,yasuhide ikenakaYasuhide Ikenaka,mitsuteru kitadeMitsuteru Kitade,kosuke kajiKosuke Kaji,junichi yoshiiJunichi Yoshii,koji yanaseKoji Yanase,masaharu yamazakiMasaharu Yamazaki,kiyoshi asadaKiyoshi Asada,tatsuhiro tsujimotoTatsuhiro Tsujimoto,takemi akahaneTakemi Akahane,masahito uemuraMasahito Uemura,hiroshi fukuiHiroshi Fukui,

    Both angiotensin-II (AT-II) and vascular endothelial growth factor (VEGF) have been shown to play important roles in the progression of liver fibrosis. However, the interaction of AT-II with VEGF in the liver fibrosis has not been elucidated yet. The aim of the current study was to elucidate a possible association between these molecules, especially in conjunction with the hepatic stellate cells (HSC). The effect of AT-II type 1 receptor blocker (ARB) was assessed on several indices of choline-deficient l-amino acid-defined (CDAA)-induced liver fibrogenesis. This ARB significantly suppressed liver fibrosis development along with suppression of the VEGF expression and neovascularization in the liver. In the cultured activated HSC, AT-II induced VEGF in a dose- and time-dependent manner. ARB and LY333531, a protein kinase C (PKC) inhibitor, attenuated this augmentation. These results indicated that AT-II and VEGF interaction played an important role in liver fibrosis development, and that in the activated HSC, AT-II utilized type 1 receptor and PKC as an intracellular signaling pathway to induce VEGF.

    Angiotensin-II and vascular endothelial growth factor interaction plays an important role in rat liver fibrosis development. Publishing Authors By Initials

    h yoshijiH Yoshiji,s kuriyamaS Kuriyama,r noguchiR Noguchi,y ikenakaY Ikenaka,m kitadeM Kitade,k kajiK Kaji,j yoshiiJ Yoshii,k yanaseK Yanase,m yamazakiM Yamazaki,k asadaK Asada,t tsujimotoT Tsujimoto,t akahaneT Akahane,m uemuraM Uemura,h fukuiH Fukui,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Angiotensin-II and vascular endothelial growth factor interaction plays an important role in rat liver fibrosis development. Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: Hepatology research : the official journal of the

    VOLUME: 36

    Page Numbers: 124-9

    Journal Abbreviation: Hepatol. Res.

    ISSN: 1386-6346

    DAY: 17

    MONTH: 08

    YEAR: 2006

    Angiotensin-II and vascular endothelial growth factor interaction plays an important role in rat liver fibrosis development. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 9711801

    Angiotensin-II and vascular endothelial growth factor interaction plays an important role in rat liver fibrosis development. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Angiotensin-II and vascular endothelial growth factor interaction plays an important role in rat liver fibrosis development. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Angiotensin-II and vascular endothelial growth factor interaction plays an important role in rat liver fibrosis development.

    AFFILIATION: Third Department of Internal Medicine, Nara Medical University, Shijo-cho 840, Kashihara, Nara 634-8522, Japan.

    Country: Netherlands

    Netherlands Research PublicationNetherlands Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Hepatol Res

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Angiotensin-II and vascular endothelial growth factor interaction plays an important role in rat liver fibrosis development Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News